A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma

Detalles Bibliográficos
Autores principales: Wang, Weidong, Lv, Wang, Wang, Hui, Xu, Yang, Yan, Junrong, Shen, Han-Ming, Shan, Liqun, Hu, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404941/
https://www.ncbi.nlm.nih.gov/pubmed/37554188
http://dx.doi.org/10.1016/j.gendis.2023.02.019
_version_ 1785085410645377024
author Wang, Weidong
Lv, Wang
Wang, Hui
Xu, Yang
Yan, Junrong
Shen, Han-Ming
Shan, Liqun
Hu, Jian
author_facet Wang, Weidong
Lv, Wang
Wang, Hui
Xu, Yang
Yan, Junrong
Shen, Han-Ming
Shan, Liqun
Hu, Jian
author_sort Wang, Weidong
collection PubMed
description
format Online
Article
Text
id pubmed-10404941
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Chongqing Medical University
record_format MEDLINE/PubMed
spelling pubmed-104049412023-08-08 A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma Wang, Weidong Lv, Wang Wang, Hui Xu, Yang Yan, Junrong Shen, Han-Ming Shan, Liqun Hu, Jian Genes Dis Rapid Communication Chongqing Medical University 2023-04-24 /pmc/articles/PMC10404941/ /pubmed/37554188 http://dx.doi.org/10.1016/j.gendis.2023.02.019 Text en © 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Rapid Communication
Wang, Weidong
Lv, Wang
Wang, Hui
Xu, Yang
Yan, Junrong
Shen, Han-Ming
Shan, Liqun
Hu, Jian
A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma
title A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma
title_full A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma
title_fullStr A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma
title_full_unstemmed A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma
title_short A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma
title_sort novel acquired egfr-sept14 fusion confers differential drug resistance to egfr inhibitors in lung adenocarcinoma
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404941/
https://www.ncbi.nlm.nih.gov/pubmed/37554188
http://dx.doi.org/10.1016/j.gendis.2023.02.019
work_keys_str_mv AT wangweidong anovelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma
AT lvwang anovelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma
AT wanghui anovelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma
AT xuyang anovelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma
AT yanjunrong anovelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma
AT shenhanming anovelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma
AT shanliqun anovelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma
AT hujian anovelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma
AT wangweidong novelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma
AT lvwang novelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma
AT wanghui novelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma
AT xuyang novelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma
AT yanjunrong novelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma
AT shenhanming novelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma
AT shanliqun novelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma
AT hujian novelacquiredegfrsept14fusionconfersdifferentialdrugresistancetoegfrinhibitorsinlungadenocarcinoma